Adverum BiotechnologiesADVM
13F holders, Q3 2024 (September 30)1holders −1
0new positions
1sold out
$7.02avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Adverum Biotechnologies Inc. (ADVM) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holder was Versant Venture Management, LLC ($3.6M).
- Company
- Adverum Biotechnologies Inc.
- CUSIP
- 00773U108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $13.8M |
All 13F filers, Q2 2024 → Q3 2024: 2,008,340 shares sold, net −2,008,340 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Versant Venture Management, LLC | 5.60% | No change | 506,821 | $3.6M |
"% of holder's portfolio" is ADVM's weight in each manager's 13F, not the share of Adverum Biotechnologies Inc. the manager owns.